Related Experiment Videos
A serine-to-proline mutation in the copper-transporting P-type ATPase gene of the macular mouse
1Institute for Experimental Animals, Hamamatsu University School of Medicine, 3600 Handa-cho, Hamamatsu 431-31, Japan.
Abstract:
We have investigated the cDNA sequence of the copper-transporting P-type ATPase (Atp7a) gene of the macular mouse, a model for human Menkes disease. A point mutation (T to C) that results in substitution of proline for serine in a putative eighth transmembrane domain of the ATP7A was identified. This contrasts with abnormalities identified in the Atp7a of other mottled mouse strains: lack of expression of Atp7a mRNA in the dappled mouse, and a splicing mutation in the blotchy mouse.
Insights
Researchers identified a specific gene mutation in macular mice, a model for Menkes disease. This copper transporter ATP7A gene defect differs from mutations found in other mouse models of the human condition.
Area of Science:
- Genetics and Molecular Biology
- Biochemistry
- Medical Research
Background:
- Menkes disease is a human genetic disorder characterized by copper transport defects.
- The copper-transporting P-type ATPase (ATP7A) gene is crucial for cellular copper homeostasis.
- The macular mouse serves as a valuable animal model for studying Menkes disease.
Purpose of the Study:
- To investigate the specific genetic defect in the Atp7a gene of the macular mouse.
- To characterize the molecular abnormality underlying copper transport dysfunction in this model.
- To compare the Atp7a mutation in macular mice with those found in other mottled mouse strains.
Main Methods:
- Complementary DNA (cDNA) sequencing of the Atp7a gene.
- Identification and characterization of point mutations.
- Comparative analysis of Atp7a gene abnormalities across different mouse models.
Main Results:
- A specific point mutation (T to C) was identified in the Atp7a gene of the macular mouse.
- This mutation leads to a substitution of proline for serine in a putative eighth transmembrane domain of the ATP7A protein.
- This molecular defect is distinct from the lack of mRNA expression in dappled mice and the splicing mutation in blotchy mice.
Conclusions:
- The identified point mutation in the Atp7a gene is the molecular basis for the Menkes disease phenotype in the macular mouse.
- This finding highlights the diverse genetic mechanisms underlying copper transport defects in different mouse models of Menkes disease.
- Understanding these distinct mutations aids in elucidating the complex role of ATP7A in copper metabolism and disease pathogenesis.